Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$62.39 - $113.8 $100,510 - $183,331
-1,611 Reduced 1.34%
118,225 $13.5 Million
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $14,965 - $21,506
-254 Reduced 0.21%
119,836 $7.42 Million
Q2 2022

Aug 10, 2022

SELL
$79.4 - $116.36 $138,950 - $203,630
-1,750 Reduced 1.44%
120,090 $9.58 Million
Q1 2022

May 12, 2022

BUY
$86.42 - $109.81 $159,444 - $202,599
1,845 Added 1.54%
121,840 $12.8 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $82,199 - $100,004
834 Added 0.7%
119,995 $12.9 Million
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $33,547 - $40,285
-365 Reduced 0.31%
119,161 $13.1 Million
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $70,285 - $78,174
815 Added 0.69%
119,526 $11.2 Million
Q1 2021

May 12, 2021

SELL
$71.83 - $95.48 $1.31 Million - $1.74 Million
-18,243 Reduced 13.32%
118,711 $10.9 Million
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $1.34 Million - $1.69 Million
-20,040 Reduced 12.76%
136,954 $10 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $603,884 - $873,954
-10,934 Reduced 6.51%
156,994 $12.2 Million
Q2 2020

Aug 13, 2020

SELL
$30.2 - $56.98 $399,848 - $754,415
-13,240 Reduced 7.31%
167,928 $9.33 Million
Q1 2020

May 12, 2020

SELL
$24.87 - $38.56 $46,904 - $72,724
-1,886 Reduced 1.03%
181,168 $5.37 Million
Q4 2019

Feb 06, 2020

BUY
$25.43 - $36.67 $290,741 - $419,248
11,433 Added 6.66%
183,054 $6.63 Million
Q3 2019

Nov 05, 2019

BUY
$23.0 - $27.97 $3.95 Million - $4.8 Million
171,621 New
171,621 $4.67 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track 1492 Capital Management LLC Portfolio

Follow 1492 Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.